Jue Wang

Dr. Jue Wang


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2023 in Pharmacological Research
Verified
Journal Article
Open access
CXCong Xu
Cong Xu
ZJZe-Bo Jiang
Ze-Bo Jiang
LSLe Shao
Le Shao
ZZZi-Ming Zhao
Zi-Ming Zhao
XFXing-Xing Fan
Xing-Xing Fan
QWQibiao Wu
Qibiao Wu
Nearly half of all Asian non-small cell lung cancer (NSCLC) patients harbour epidermal growth factor receptor (EGFR) mutations, and first-generation EGFR tyrosine kinase inhibitors (TKIs) are one of the first-line treatments that have improved the outcomes of these patients. Unfortunately, 20% of these patients can not benefit from the treatment. The basis of this primary resistance is poorly understood. Therefore, overcoming EGFR-TKI primary resistance and maintaining the efficacy of TKIs has become a key issue. β-Elemene, a sesquiterpene compound extracted from Curcuma aromatica Salisb. (wenyujing), has shown potent antitumor effects. In this research, we found that β-elemene combined with erlotinib enhanced the cytotoxicity of erlotinib to primary EGFR-TKI-resistant NSCLC cells with EGFR mutations and that ferroptosis was involved in the antitumor effect of the combination treatment. We found that lncRNA H19 was significantly downregulated in primary EGFR-TKI-resistant NSCLC cell lines and was upregulated by the combination treatment. Overexpression or knockdown of H19 conferred sensitivity or resistance to erlotinib, respectively, in both in vitro and in vivo studies. The high level of H19 enhanced the cytotoxicity of erlotinib by inducing ferroptosis. In conclusion, our data showed that β-elemene combined with erlotinib could enhance sensitivity to EGFR-TKIs through induction of ferroptosis via H19 in primary EGFR-TKI-resistant lung cancer, providing a promising strategy to overcome EGFR-TKI resistance in NSCLC patients.

Hongwei ChenHongwei Chen
Hongwei Chen
JWJue Wang
Jue Wang
ZLZheng Li
Zheng Li
CLChristopher Wai Kei Lam
Christopher Wai Kei Lam
YXYing Xiao
Ying Xiao
WZWei Zhang
Wei Zhang
Background: Non-alcoholic fatty liver disease (NAFLD) is a serious health problem, but the dose-response relationship between sugar-sweetened beverages (SSBs) and NAFLD remains uncertain. Methods: A systematic review and dose-response meta-analysis were conducted following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Review Manager 5.3 and Stata 14.0 were used to combine trials and analyze data. The dose-response meta-analysis was performed by non-linear trend regression. Results: Twelve studies recruiting a total of 35,705 participants were included. The results showed that the consumption of SSBs was associated with 1.39-fold increased odds of NAFLD (95% CI: 1.29–1.50, p < 0.00001). The risk of NAFLD rose with an increased consumption of SSBs, while the consumptions of low doses (<1 cup/week), middle doses (1–6 cups/week) and high doses (≥7 cups/week) of SSBs increased the relative risk of NAFLD by 14%, 26% and 53%, respectively (p = 0.01, p < 0.00001, p = 0.03, respectively). Conclusions: This study demonstrates that consumers of SSBs are at significantly increased risk of NAFLD, and the consumption of SSBs has a dose-dependent effect on the risk of NAFLD. The findings of this study strengthen the evidence base for healthy dietary patterns and are meaningful for the primary prevention of NAFLD.

1 June 2019 in Phytomedicine
Verified
Journal Article
Closed access
XWXuewei Wang
Xuewei Wang
ZLZhengtang Liu
Zhengtang Liu
XSXinbing Sui
Xinbing Sui
QWQibiao Wu
Qibiao Wu
JWJue Wang
Jue Wang
CXCong Xu
Cong Xu


30 July 2025 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
LALu An
Lu An
YHYali Huang
Yali Huang
YWYunkai Wang
Yunkai Wang
SSShuting Shen
Shuting Shen
XLXuexing Luo
Xuexing Luo
YLYu Li
Yu Li
Objective: This study systematically assess the potential impact of various environmental pollutants as chemical, airborne, and heavy metal on ovarian function in women, focusing on ovarian reserve such as anti-Müllerian hormone (AMH) and antral follicle count (AFC) as well as hormone levels like follicle-stimulating hormone (FSH) and estradiol (E2). By reviewing epidemiological evidence, this research aims to elucidate the reproductive toxicity of these pollutants and provide scientific support for public health policy to protect reproductive health in women of childbearing age.Methods: Following the PRISMA-P guidelines, a comprehensive search was conducted in PubMed, EMBASE, Cochrane Library, and Web of Science databases to include all relevant studies up to July 30, 2024. The Newcastle-Ottawa Scale (NOS) and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach were used to assess study quality.Results: This study ultimately included 40 cohort study reports derived from 33 distinct studies that analyzed the effects of 20 pollutant types on ovarian function. Results indicate that pollutants, such as perfluoroalkyl and polyfluoroalkyl substances (PFAS), phthalates (PAEs), triclosan, Polychlorinated Biphenyls (PCBs), PM2.5, and SOX, have a significantly negative impact on ovarian function, especially among younger women (<35 years). Long-term exposure to particulate matter (PM)2.5 and PM10 is associated with a substantial decrease in ovarian reserve, while heavy metals (e.g., lead and cadmium) also demonstrate reproductive toxicity. However, these conclusions require validation due to both methodological limitations in the original studies (e.g., heterogeneous exposure assessments and residual confounding) and challenges in evidence synthesis (e.g., inconsistent outcome measures across cohorts), highlighting the need for further research to address these constraints.Conclusion: This review underscores that specific pollutants (e.g., PCBs, PFAS, PM) pose substantial risks to reproductive health in women of childbearing age, particularly in highly polluted environments. The findings underscore the importance of regular ovarian health monitoring, especially for women at higher risk due to occupational or environmental factors.Systematic review registration: PROSPERO CRD42024567744 (accessible at https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42024567744).

8 October 2024 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
AZAijia Zhang
Aijia Zhang
XLXuexing Luo
Xuexing Luo
YLYu Li
Yu Li
LYLunchun Yan
Lunchun Yan
XLXin Lai
Xin Lai
JWJue Wang
Jue Wang
Lung cancer remains the leading cause of cancer-related mortality globally, with environmental pollutants identified as significant risk factors, especially for nonsmokers. The intersection of these pollutants with epigenetic mechanisms has emerged as a critical area of interest for understanding the etiology and progression of lung cancer. Epigenetic changes, including DNA methylation, histone modifications, and non-coding RNAs, can induce alterations in gene expression without affecting the DNA sequence and are influenced by environmental factors, contributing to the transformation of normal cells into malignant cells. This review assessed the literature on the influence of environmental pollutants on lung cancer epigenetics. A comprehensive search across databases such as PubMed, Web of Science, Cochrane Library, and Embase yielded 3,254 publications, with 22 high-quality papers included for in-depth analysis. These studies demonstrated the role of epigenetic markers, such as DNA methylation patterns of genes like F2RL3 and AHRR and alterations in the miRNA expression profiles, as potential biomarkers for lung cancer diagnosis and treatment. The review highlights the need to expand research beyond homogenous adult male groups typically found in high-risk occupational environments to broader population demographics. Such diversification can reduce biases and enhance the relevance of findings to various clinical contexts, fostering the development of personalized preventive and therapeutic measures. In conclusion, our findings underscore the potential of innovative epigenetic therapies, such as DNA demethylating drugs and histone modification agents, to counter environmental toxins’ carcinogenic effects. The growing interest in miRNA therapies and studies aiming to correct aberrant methylation patterns indicate significant strides toward better lung cancer management and a healthier future for global communities.